These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 26441970)

  • 21. Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors.
    Jie KE; Verhaar MC; Cramer MJ; van der Putten K; Gaillard CA; Doevendans PA; Koomans HA; Joles JA; Braam B
    Am J Physiol Renal Physiol; 2006 Nov; 291(5):F932-44. PubMed ID: 16885153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiorenal syndrome.
    Mahapatra HS; Lalmalsawma R; Singh NP; Kumar M; Tiwari SC
    Iran J Kidney Dis; 2009 Apr; 3(2):61-70. PubMed ID: 19395780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypertensive renal vascular disease and cardiovascular endpoints.
    Matavelli LC; Zhou X; Frohlich ED
    Curr Opin Cardiol; 2006 Jul; 21(4):305-9. PubMed ID: 16755198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human cytomegalovirus infection is a novel etiology for essential hypertension.
    Zhang M; Yang Y; Yang X; Cai J
    Med Hypotheses; 2011 May; 76(5):682-4. PubMed ID: 21316863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. L-arginine or tempol supplementation improves renal and cardiovascular function in rats with reduced renal mass and chronic high salt intake.
    Carlström M; Brown RD; Yang T; Hezel M; Larsson E; Scheffer PG; Teerlink T; Lundberg JO; Persson AE
    Acta Physiol (Oxf); 2013 Apr; 207(4):732-41. PubMed ID: 23387940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The cardiorenal syndrome and erythropoietin].
    Kes P; Basić-Jukić N; Jurić I; Basić-Kes V
    Acta Med Croatica; 2008; 62 Suppl 1():21-31. PubMed ID: 18578329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. When cardiac failure, kidney dysfunction, and kidney injury intersect in acute conditions: the case of cardiorenal syndrome.
    Legrand M; Mebazaa A; Ronco C; Januzzi JL
    Crit Care Med; 2014 Sep; 42(9):2109-17. PubMed ID: 24810531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heart and kidneys: sharing more than just blood.
    Stafford-Smith M
    Curr Opin Anaesthesiol; 2007 Feb; 20(1):65-9. PubMed ID: 17211170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Urinary albumin excretion and noninvasive assessment of peripheral endothelial dysfunction with high-resolution ultrasound in type 2 diabetic subjects and nondiabetic controls].
    Balletshofer BM; Braun B; Rittig K; Stock J; Riexinger A; Lehn-Stefan A; Häring HU
    Med Klin (Munich); 2003 Apr; 98(5):253-8. PubMed ID: 12721669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pathophysiological and clinical correlations between endocrine and cardiovascular systems. An inter-systemic model of internal medicine].
    Andreoli M
    Recenti Prog Med; 2006 Dec; 97(12):679-96. PubMed ID: 17252726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular risk in diabetic end-stage renal disease patients.
    Wang AY
    J Diabetes; 2011 Jun; 3(2):119-31. PubMed ID: 21599866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review).
    Siti HN; Kamisah Y; Kamsiah J
    Vascul Pharmacol; 2015 Aug; 71():40-56. PubMed ID: 25869516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic renal dysfunction as an independent risk factor for the development of cardiovascular disease.
    Varma R; Garrick R; McClung J; Frishman WH
    Cardiol Rev; 2005; 13(2):98-107. PubMed ID: 15705261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiorenal syndrome: pathophysiological mechanism, preclinical models, novel contributors and potential therapies.
    Fu Q; Cao L; Li H; Wang B; Li Z
    Chin Med J (Engl); 2014; 127(16):3011-8. PubMed ID: 25131243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cardiorenal syndromes].
    Késöi I; Sági B; Vas T; Pintér T; Kovács T; Wittmann I; Nagy J
    Orv Hetil; 2011 Sep; 152(38):1520-7. PubMed ID: 21896443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obesity hypertension: the emerging role of leptin in renal and cardiovascular dyshomeostasis.
    Kshatriya S; Reams GP; Spear RM; Freeman RH; Dietz JR; Villarreal D
    Curr Opin Nephrol Hypertens; 2010 Jan; 19(1):72-8. PubMed ID: 19851106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zinc restriction during different periods of life: influence in renal and cardiovascular diseases.
    Tomat AL; Costa Mde L; Arranz CT
    Nutrition; 2011 Apr; 27(4):392-8. PubMed ID: 21074972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitric oxide-independent stimulation of soluble guanylate cyclase reduces organ damage in experimental low-renin and high-renin models.
    Sharkovska Y; Kalk P; Lawrenz B; Godes M; Hoffmann LS; Wellkisch K; Geschka S; Relle K; Hocher B; Stasch JP
    J Hypertens; 2010 Aug; 28(8):1666-75. PubMed ID: 20613628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exercise training upregulates nitric oxide synthases in the kidney of rats with chronic heart failure.
    Ito D; Ito O; Mori N; Cao P; Suda C; Muroya Y; Hao K; Shimokawa H; Kohzuki M
    Clin Exp Pharmacol Physiol; 2013 Sep; 40(9):617-25. PubMed ID: 23735016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiorenal Syndrome in Acute Heart Failure: Revisiting Paradigms.
    Núñez J; Miñana G; Santas E; Bertomeu-González V
    Rev Esp Cardiol (Engl Ed); 2015 May; 68(5):426-35. PubMed ID: 25758162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.